Christopher Henney
2016
In 2016, Christopher Henney earned a total compensation of $259.8K as Chairman of the Board and Former Interim President, Chief Executive Officer at Oncothyreon.
Compensation breakdown
| Option Awards | $104,750 |
|---|---|
| Salary | $105,000 |
| Stock Awards | $50,000 |
| Total | $259,750 |
Henney received $105K in salary, accounting for 40% of the total pay in 2016.
Henney also received $104.8K in option awards and $50K in stock awards.
Rankings
In 2016, Christopher Henney's compensation ranked 12,982nd out of 14,075 executives tracked by ExecPay. In other words, Henney earned more than 7.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,982 out of 14,075 | 8th |
Division Services | 2,081 out of 2,282 | 9th |
Major group Engineering, Accounting, Research, Management, And Related Services | 165 out of 184 | 10th |
Industry group Research, Development, And Testing Services | 53 out of 59 | 10th |
Industry Commercial Physical and Biological Research | 49 out of 55 | 11th |
Source: SEC filing on April 26, 2017.
Henney's colleagues
We found six more compensation records of executives who worked with Christopher Henney at Oncothyreon in 2016.
2016
Scott Myers
Oncothyreon
Chief Executive Officer
2016
Robert Kirkman
Oncothyreon
Chief Executive Officer
2016
Scott Peterson
Oncothyreon
Chief Scientific Officer
2016
Julia Eastland
Oncothyreon
Chief Financial Officer
2016
Gary Christianson
Oncothyreon
Chief Operating Officer
2016
Diana Hausman
Oncothyreon